L González1, C Corvalán1, A Pereira1, J Kain1, M L Garmendia1, R Uauy2. 1. Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile. 2. 1] Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile [2] The London School of Hygiene and Tropical Medicine, London, UK.
Abstract
BACKGROUND: Early adiposity rebound (AR <5 years) has been consistently associated with increased obesity risk, but its relationship with metabolic markers is less clear; in addition, the biologic mechanisms involved in these associations have not been established. OBJECTIVE: The objective of this study was to assess the association between timing of AR and metabolic status at age 7 years, evaluating the potential role of adiposity, adipose functionality and skeletal maturation in this association. DESIGN: We estimated the age of AR from the body mass index (BMI) trajectories from 0 to 7 years in 910 children from the Growth and Obesity Chilean Cohort Study (GOCS). At 7 years, we measured waist circumference (WC) and blood glucose, insulin, triglycerides and high-density lipoprotein-cholesterol levels and constructed a metabolic risk score. We also measured percent fat mass (adiposity), plasma concentrations of leptin and adiponectin (adipose functionality) and bone age using wrist ultrasound (skeletal maturation). RESULTS: We found that 44% of the children had an AR <5 years. Earlier AR was associated with larger WC (β: 5.10 (95% confidence interval (CI): 4.29-5.91)), higher glucose (β: 1.02 (1.00-1.03)), insulin resistance (β Homeostatic Model Assessment: 1.06 (1.03-1.09)), triglycerides (β: 10.37 (4.01-6.73)) and adverse metabolic score (β: 0.30 (0.02-0.37)). Associations decreased significantly if adiposity was added to the models (i.e. β WC: 0.85 (0.33-1.38)) and, to a lesser extent, when adipokines (i.e. β WC: 0.73 (0.14-1.32)) and skeletal maturation (i.e. β WC: 0.65 (0.10-1.20)) were added. CONCLUSION: In GOCS children, AR at a younger age predicts higher metabolic risk at 7 years; these associations are mostly explained by increased adiposity, but adipose dysfunction and accelerated skeletal maturation also have a role.
BACKGROUND: Early adiposity rebound (AR <5 years) has been consistently associated with increased obesity risk, but its relationship with metabolic markers is less clear; in addition, the biologic mechanisms involved in these associations have not been established. OBJECTIVE: The objective of this study was to assess the association between timing of AR and metabolic status at age 7 years, evaluating the potential role of adiposity, adipose functionality and skeletal maturation in this association. DESIGN: We estimated the age of AR from the body mass index (BMI) trajectories from 0 to 7 years in 910 children from the Growth and Obesity Chilean Cohort Study (GOCS). At 7 years, we measured waist circumference (WC) and blood glucose, insulin, triglycerides and high-density lipoprotein-cholesterol levels and constructed a metabolic risk score. We also measured percent fat mass (adiposity), plasma concentrations of leptin and adiponectin (adipose functionality) and bone age using wrist ultrasound (skeletal maturation). RESULTS: We found that 44% of the children had an AR <5 years. Earlier AR was associated with larger WC (β: 5.10 (95% confidence interval (CI): 4.29-5.91)), higher glucose (β: 1.02 (1.00-1.03)), insulin resistance (β Homeostatic Model Assessment: 1.06 (1.03-1.09)), triglycerides (β: 10.37 (4.01-6.73)) and adverse metabolic score (β: 0.30 (0.02-0.37)). Associations decreased significantly if adiposity was added to the models (i.e. β WC: 0.85 (0.33-1.38)) and, to a lesser extent, when adipokines (i.e. β WC: 0.73 (0.14-1.32)) and skeletal maturation (i.e. β WC: 0.65 (0.10-1.20)) were added. CONCLUSION: In GOCS children, AR at a younger age predicts higher metabolic risk at 7 years; these associations are mostly explained by increased adiposity, but adipose dysfunction and accelerated skeletal maturation also have a role.
Authors: Mariska van Vliet; Martijn W Heymans; Inès A von Rosenstiel; Desiderius P M Brandjes; Jos H Beijnen; Michaela Diamant Journal: Cardiovasc Diabetol Date: 2011-11-24 Impact factor: 9.951
Authors: Izzuddin M Aris; Sheryl L Rifas-Shiman; Ling-Jun Li; Ken P Kleinman; Brent A Coull; Diane R Gold; Marie-France Hivert; Michael S Kramer; Emily Oken Journal: Int J Epidemiol Date: 2019-02-01 Impact factor: 7.196
Authors: C Börnhorst; A Siani; M Tornaritis; D Molnár; L Lissner; S Regber; L Reisch; A De Decker; L A Moreno; W Ahrens; I Pigeot Journal: Int J Obes (Lond) Date: 2016-11-30 Impact factor: 5.095
Authors: Edward H Ip; Sarah A Marshall; Santiago Saldana; Joseph A Skelton; Cynthia K Suerken; Thomas A Arcury; Sara A Quandt Journal: J Pediatr Date: 2017-02-24 Impact factor: 4.406
Authors: Izzuddin M Aris; Jonathan Y Bernard; Ling-Wei Chen; Mya Thway Tint; Wei Wei Pang; Wai Yee Lim; Shu E Soh; Seang-Mei Saw; Keith M Godfrey; Peter D Gluckman; Yap-Seng Chong; Fabian Yap; Michael S Kramer; Yung Seng Lee Journal: Int J Epidemiol Date: 2017-04-01 Impact factor: 7.196
Authors: S Péneau; R González-Carrascosa; G Gusto; D Goxe; O Lantieri; L Fezeu; S Hercberg; M F Rolland-Cachera Journal: Int J Obes (Lond) Date: 2016-03-22 Impact factor: 5.095
Authors: Gagandeep Bhullar; Veeraya K Tanawattanacharoen; Mei Y Yeh; William S Kim; Alaina P Vidmar; Mitchell E Geffner; Darryl H Hwang; Mimi S Kim Journal: Horm Res Paediatr Date: 2021-03-10 Impact factor: 2.852
Authors: Alexandra M Binder; Leah T Stiemsma; Kristen Keller; Sanne D van Otterdijk; Verónica Mericq; Ana Pereira; José L Santos; John Shepherd; Karin B Michels Journal: Clin Epigenetics Date: 2018-10-04 Impact factor: 6.551